In the Spotlight

• 19 December 2012

  RMI and Domain Associates to invest $93m in development of three next-generation pharmaceuticals

  U.S. venture capital firm Domain Associates, Rusnano subsidiary RusnanoMedInvest (RMI) and a group of co-investors will invest a combined $93m in Marinus Pharmaceuticals, Inc., Lithera, Inc., and Regado Biosciences, Inc., all of which are developers of advanced pharmaceutical products.

• 07 August 2012

  

  There is practically no venture financing institution in the field of Life Sciences in Russia

  Kirill Sedov, Farmatsevticheskiy Vestnik

  In the interview to Farmatsevticheskiy Vestnik, Leonid Melamed, Team Drive Chairman of the Board of Directors said that the company having undertaken a venture project in the Russian pharmaceutical market had to act as a pioneer.

Preview 1 2 3